AJP - Lung Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol 288: L793-L802, 2005. First published November 24, 2004; doi:10.1152/ajplung.00343.2004
1040-0605/05 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
288/5/L793    most recent
00343.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (13)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sokolova, E.
Right arrow Articles by Reiser, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sokolova, E.
Right arrow Articles by Reiser, G.

ARTICLE

EDITORIAL FOCUS

Protease-activated receptor-1 in human lung fibroblasts mediates a negative feedback downregulation via prostaglandin E2

Elena Sokolova,1,* Zoryana Grishina,1,2,* Frank Bühling,3 Tobias Welte,4 and Georg Reiser1

Otto-von-Guericke-Universität Magdeburg, Medizinische Fakultät, Institut für 1Neurobiochemie and 3Immunologie, 4Klinik für Kardiologie, Angiologie und Pneumologie; Magdeburg, Germany; and 2Belozersky Institute of Physico-Chemical Biology, Moscow State University, Moscow, Russia

Submitted 15 September 2004 ; accepted in final form 19 November 2004

Among the four protease-activated receptors (PARs), PAR-1 plays an important role in normal lung functioning and in the development of lung diseases, including fibrosis. We compared the expression and functional activity of PARs in normal and fibrotic human lung fibroblasts. Both normal and fibrotic cells express PAR-1, -2, and -3, with PAR-2 showing the lowest level. There was no significant difference between normal and fibrotic fibroblasts in expression levels of PAR-1 and PAR-3, whereas a fourfold higher expression level of PAR-2 was observed in fibrotic cells compared with normal cells. Ca2+ imaging studies revealed apparently only PAR-1-induced Ca2+ signaling in lung fibroblasts. PAR-1 agonists, thrombin and synthetic activating peptide, induced concentration-dependent Ca2+ mobilization with EC50 values of 5 nM and 1 µM, respectively. The neutrophil protease cathepsin G produced a transient Ca2+ response followed by disabling PAR-1, whereas elastase did not affect Ca2+ level. PAR-1 activation by thrombin or receptor-activating peptide downregulated expression of all three PARs in lung fibroblasts, with maximal effect at 3–6 h, whereas expression returned toward basal level after 24 h. Furthermore, PAR-1 agonists dose dependently increased PGE2 secretion from lung fibroblasts and induction of cyclooxygenase-2 expression. We then found that PGE2 downregulated expression of all three PARs. The effect of PGE2 was continuously growing with time. Furthermore, PGE2 exerts its effect through the EP2 receptor that was confirmed using the selective EP2 agonist butaprost. This novel autocrine feedback mechanism of PGE2 in lung fibroblasts seems to be an important regulator in lung physiology and pathology.

thrombin; cyclooxygenase; cyclic adenosine 5'-monophosphate; prostanoid



Address for reprint requests and other correspondence: Prof. Dr. G. Reiser, Otto-von-Guericke-Universität Magdeburg, Medizinische Fakultät, Institut für Neurobiochemie, Leipziger Strasse 44, D-39120, Magdeburg, Germany (E-mail: Georg.Reiser{at}Medizin.Uni-Magdeburg.de)




This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
W. R. Coward, K. Watts, C. A. Feghali-Bostwick, A. Knox, and L. Pang
Defective Histone Acetylation Is Responsible for the Diminished Expression of Cyclooxygenase 2 in Idiopathic Pulmonary Fibrosis
Mol. Cell. Biol., August 1, 2009; 29(15): 4325 - 4339.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
R. S. Sacks, A. L. Firth, C. V. Remillard, N. Agange, J. Yau, E. A. Ko, and J. X.-J. Yuan
Thrombin-mediated increases in cytosolic [Ca2+] involve different mechanisms in human pulmonary artery smooth muscle and endothelial cells
Am J Physiol Lung Cell Mol Physiol, December 1, 2008; 295(6): L1048 - L1055.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. Pape, B. H. Rauch, A. C. Rosenkranz, G. Kaber, and K. Schror
Transcriptional Inhibition of Protease-Activated Receptor-1 Expression by Prostacyclin in Human Vascular Smooth Muscle Cells
Arterioscler Thromb Vasc Biol, March 1, 2008; 28(3): 534 - 540.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
E. Ostrowska, E. Sokolova, and G. Reiser
PAR-2 activation and LPS synergistically enhance inflammatory signaling in airway epithelial cells by raising PAR expression level and interleukin-8 release
Am J Physiol Lung Cell Mol Physiol, November 1, 2007; 293(5): L1208 - L1218.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
R. Ramachandran, L. R. Sadofsky, Y. Xiao, A. Botham, M. Cowen, A. H. Morice, and S. J Compton
Inflammatory mediators modulate thrombin and cathepsin-G signaling in human bronchial fibroblasts by inducing expression of proteinase-activated receptor-4
Am J Physiol Lung Cell Mol Physiol, March 1, 2007; 292(3): L788 - L798.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
G. J. Laurent
No Bit PARt for PAR-1
Am. J. Respir. Cell Mol. Biol., September 1, 2005; 33(3): 213 - 215.
[Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
C. V. Remillard and J. X.-J. Yuan
PGE2 and PAR-1 in pulmonary fibrosis: a case of biting the hand that feeds you?
Am J Physiol Lung Cell Mol Physiol, May 1, 2005; 288(5): L789 - L792.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.